Search research articles
Contact Us
Filters
Showing results (81-90 of 400) with videos related to
Page
of 40
Sort By:
Oncolytic Virotherapy
|
December 14, 2016
CXCL12 retargeting of an adenovirus vector to cancer cells using a bispecific adapter
Shilpa Bhatia, Samia M O'Bryan, Angel A Rivera, et al.
Cancer Research
|
February 7, 2007
Establishment of a new interleukin-6 (IL-6) receptor inhibitor applicable to the gene therapy for IL-6-dependent tumor
Naoko Yoshio-Hoshino, Yasuo Adachi, Chieko Aoki, et al.
The Journal of General Virology
|
November 22, 2005
Fluorescently tagged canine adenovirus via modification with protein IX-enhanced green fluorescent protein
Long P Le, Jing Li, Vladimir V Ternovoi, et al.
International Journal of Cancer
|
April 28, 2006
Interleukin-6 induces both cell growth and VEGF production in malignant mesotheliomas
Yasuo Adachi, Chieko Aoki, Naoko Yoshio-Hoshino, et al.
Cancer Gene Therapy
|
July 23, 2003
Production of an EGFR targeting molecule from a conditionally replicating adenovirus impairs its oncolytic potential
Akseli Hemminki, Minghui Wang, Tanja Hakkarainen, et al.
Molecular Cancer Therapeutics
|
December 13, 2002
Conditionally replicative adenoviruses for ovarian cancer therapy
Mack N Barnes, Candace J Coolidge, Akseli Hemminki, et al.
ACS Nano
|
June 24, 2022
Efficient Genome Editing Achieved via Plug-and-Play Adenovirus Piggyback Transport of Cas9/gRNA Complex on Viral Capsid Surface
Zhi Hong Lu, Jie Li, Igor P Dmitriev, et al.
Human Gene Therapy
|
September 14, 2002
Double modification of adenovirus fiber with RGD and polylysine motifs improves coxsackievirus-adenovirus receptor-independent gene transfer efficiency
Hongju Wu, Toshiro Seki, Igor Dmitriev, et al.
Plos One
|
September 24, 2010
Transduction of brain dopamine neurons by adenoviral vectors is modulated by CAR expression: rationale for tropism modified vectors in PD gene therapy
Travis B Lewis, Joel N Glasgow, Anya M Glandon, et al.
Molecular Cancer Therapeutics
|
June 24, 2004
Transcriptional targeting in renal cancer cell lines via the human CXCR4 promoter
Yosef S Haviv, Winan J van Houdt, Baogen Lu, et al.
Page
of 40
Search research articles
Search
Showing results (81-90 of 400) with videos related to
Sort By:
Page
of 40
Oncolytic Virotherapy
|
December 14, 2016
CXCL12 retargeting of an adenovirus vector to cancer cells using a bispecific adapter
Shilpa Bhatia, Samia M O'Bryan, Angel A Rivera, et al.
Cancer Research
|
February 7, 2007
Establishment of a new interleukin-6 (IL-6) receptor inhibitor applicable to the gene therapy for IL-6-dependent tumor
Naoko Yoshio-Hoshino, Yasuo Adachi, Chieko Aoki, et al.
The Journal of General Virology
|
November 22, 2005
Fluorescently tagged canine adenovirus via modification with protein IX-enhanced green fluorescent protein
Long P Le, Jing Li, Vladimir V Ternovoi, et al.
International Journal of Cancer
|
April 28, 2006
Interleukin-6 induces both cell growth and VEGF production in malignant mesotheliomas
Yasuo Adachi, Chieko Aoki, Naoko Yoshio-Hoshino, et al.
Cancer Gene Therapy
|
July 23, 2003
Production of an EGFR targeting molecule from a conditionally replicating adenovirus impairs its oncolytic potential
Akseli Hemminki, Minghui Wang, Tanja Hakkarainen, et al.
Molecular Cancer Therapeutics
|
December 13, 2002
Conditionally replicative adenoviruses for ovarian cancer therapy
Mack N Barnes, Candace J Coolidge, Akseli Hemminki, et al.
ACS Nano
|
June 24, 2022
Efficient Genome Editing Achieved via Plug-and-Play Adenovirus Piggyback Transport of Cas9/gRNA Complex on Viral Capsid Surface
Zhi Hong Lu, Jie Li, Igor P Dmitriev, et al.
Human Gene Therapy
|
September 14, 2002
Double modification of adenovirus fiber with RGD and polylysine motifs improves coxsackievirus-adenovirus receptor-independent gene transfer efficiency
Hongju Wu, Toshiro Seki, Igor Dmitriev, et al.
Plos One
|
September 24, 2010
Transduction of brain dopamine neurons by adenoviral vectors is modulated by CAR expression: rationale for tropism modified vectors in PD gene therapy
Travis B Lewis, Joel N Glasgow, Anya M Glandon, et al.
Molecular Cancer Therapeutics
|
June 24, 2004
Transcriptional targeting in renal cancer cell lines via the human CXCR4 promoter
Yosef S Haviv, Winan J van Houdt, Baogen Lu, et al.
Page
of 40